Exact Mass: 251.170761
Exact Mass Matches: 251.170761
Found 224 metabolites which its exact mass value is equals to given mass value 251.170761,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Prosulfocarb
CONFIDENCE standard compound; EAWAG_UCHEM_ID 71 CONFIDENCE standard compound; INTERNAL_ID 4063 CONFIDENCE standard compound; INTERNAL_ID 2570 CONFIDENCE standard compound; INTERNAL_ID 8398
N-desmethylmirtazapine
N-desmethylmirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia)
Didesmethyl doxepin
Didesmethyl doxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)
[3h]Thienylcyclohexylpiperidine
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents
Didesmethylsibutramine
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
Besipirdine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
4-Amino-1-[(1S,2S,4S)-4,5-bis(hydroxymethyl)-2-bicyclo[3.1.0]hexanyl]pyrimidin-2-one
Dihydroalprenolol
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Midaglizole
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D007004 - Hypoglycemic Agents Midaglizole ((±)-DG5128 free base; DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo[1][2][3]. Midaglizole ((±)-DG5128 free base; DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo[1][2][3].
Tempo-maleimide
2-(Benzyloxyamino)-4-methylvaleric acid methyl ester
2-Phenylethylamide-(E)-2-Nonene-6,8-diynoic acid|nona-2E-en-6,8-diynoic acid 2-phenylethylamide
(2E,6E,8E)-N-(2-hydroxy-2-methylpropyl)-10-oxo-2,6,8-decatrienamide
4-(6-furan-3-yl-3-methyl-piperidin-2-yl)-2-methyl-butan-1-ol|Dihydronuphamin|Secodihydrocastoramin
(E)-3-phenyl-N-(2-phenylethyl)prop-2-enamide
2,6-Di-tert-butyl-4-nitrophenol
CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5562; ORIGINAL_PRECURSOR_SCAN_NO 5560 CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5558; ORIGINAL_PRECURSOR_SCAN_NO 5557 CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5585; ORIGINAL_PRECURSOR_SCAN_NO 5584 CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5579; ORIGINAL_PRECURSOR_SCAN_NO 5576 CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5661; ORIGINAL_PRECURSOR_SCAN_NO 5657 CONFIDENCE standard compound; INTERNAL_ID 299; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5581; ORIGINAL_PRECURSOR_SCAN_NO 5580
(E)-3-phenyl-N-(2-phenylethyl)prop-2-enamide_major
(E)-3-phenyl-N-(2-phenylethyl)prop-2-enamide_2.3\\%
(7R,8R,E)-8-methyl-6-((R)-2-methylpent-4-en-1-ylidene)octahydroindolizine-7,8-diol
(5R)-5-methyl-6-((Z)-1,2,3,8a-tetrahydroindolizin-6(5H)-ylidene)hexane-2,3-diol
4-Hydrazinyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester hydrochloride
tert-butyl 3-formyl-6,7-dihydro-5H-pyrazolo[1,5-a]pyrimidine-4-carboxylate
(R)-N-(Methoxymethyl)-1-phenyl-N-((trimethylsilyl)methyl)ethanamine
C14H25NOSi (251.17053199999998)
2-(2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-ethylamine
2-(1H-indol-3-yl)-N-(pyridin-3-ylmethyl)ethanamine
Xibenolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
6-(cyclohexylcarbamoyl)cyclohex-3-ene-1-carboxylic acid
(S)-(-)-N-Methoxymethyl-n-trimethylsilylmethyl-1-phenylethylamine
C14H25NOSi (251.17053199999998)
1,2-bis(ethenyl)benzene,2-methylbuta-1,3-diene,prop-2-enenitrile
2-Methyl-2-propanyl 4-(1H-imidazol-4-yl)-1-piperidinecarboxylate
(2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethyl-pentanamine
ETHYL 3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONATE
2-(4-(4-AMINO-3-METHOXYPHENYL)PIPERAZIN-1-YL)ETHANOL
methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate
methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-2-carboxylate
tert-butyl 4-oxo-3,4,5,6-tetrahydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate
1H-Imidazole-4-carboxylicacid,5-[(cyclohexylamino)carbonyl]-,hydrazide
TERT-BUTYL ((1R,2S)-3,3-DIFLUORO-2-HYDROXYCYCLOHEXYL)CARBAMATE
tert-butyl 4-(1H-pyrazol-1-yl)piperidine-1-carboxylate
BENZYL (1-AMINO-1-(HYDROXYIMINO)-2-METHYLPROPAN-2-YL)CARBAMATE
ETHYL 4-HYDROXY-2-(PIPERIDIN-1-YL)PYRIMIDINE-5-CARBOXYLATE
ETHYL 4-METHYL-2-MORPHOLINOPYRIMIDINE-5-CARBOXYLATE
TERT-BUTYL [(1S)-1-(4-METHOXYPHENYL)ETHYL]CARBAMATE
1-Piperidinecarboxylic acid, 4-(1H-pyrazol-3-yl)-, 1,1-dimethylethyl ester
tert-butyl [(1s)-1-(3-methoxyphenyl)ethyl]carbamate
(S)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE
2-(6-methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl)-ethylamine
(4-(Diethylcarbamoyl)-2-methoxyphenyl)boronic acid
tert-Butyl 7,7-dimethyl-6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-5(4H)-carboxylate
ethyl 2-(4-hydroxypiperidin-1-yl)pyrimidine-5-carboxylate
Mebeverine metabolite O-desmethyl Mebeverine alcohol
3-amino-3-[4-(3-methylbutoxy)phenyl]propanoic acid
3-((CYCLOHEXYL(METHYL)AMINO)METHYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID
5-((CYCLOHEXYL(METHYL)AMINO)METHYL)-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
1H-Benz[g]indole-3-carboxaldehyde,2-(1,1-dimethylethyl)-(9CI)
(2-(((TERT-BUTOXYCARBONYL)AMINO)METHYL)PHENYL)BORONIC ACID
tert-butyl 4-(1H-imidazol-2-yl)piperidine-1-carboxylate
tert-Butyl 4-(1H-imidazol-1-yl)piperidine-1-carboxylate
(6,7-diethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methanol
ETHYL 3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONATE
tert-butyl N-[[4-(hydroxymethyl)phenyl]methyl]-N-methylcarbamate
N-TERT-BUTYL-1,1-DIMETHYL-1-(2,3,4,5-TETRAMETHYL-2,4-CYCLOPENTADIEN-1-YL) SILANAMINE
n-Octyltrimethylammonium bromide
C11H26BrN (251.12484959999998)
1H-1,2,4-Triazole-3-carboxamide,N-(2,2,6,6-tetramethyl-4-piperidinyl)-(9CI)
C12H21N5O (251.17460160000002)
tert-butyl 3-(1H-pyrazol-5-yl)piperidine-1-carboxylate
Styrene, divinylbenzene polymer, sulfonated, ammonium salt
Benzenepropanenitrile, a-ethyl-b-hydroxy-b-phenyl-
(2R,3S)-1-(DIMETHYLAMINO)-3-(3-METHOXYPHENYL)-2-METHYLPENTAN-3-OL
6-N-BOC-5,6,7,8-TETRAHYDRO-PYRIDO[4,3-C]PYRIDAZIN-3-OL
Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI)
1-(4-(ALLYLOXY)-3,5-DIMETHOXYPHENYL)PROPAN-2-AMINE
2-(2-butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylacetamide
(R)-1-(1,2-DIHYDROACENAPHTHYLEN-1-YL)PIPERIDIN-4-ONE
(2R,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methyl-3-pentanol
2-(1,1,3-triMethyl-1H-benzo[e]indol-2(3H)-ylidene)acetaldehyde
METHYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-1-CARBOXYLATE
4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE-1-ACETAMIDE
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone
N-(ethoxymethyl)-N-(2-ethyl-6-methyl-phenyl)-2-hydroxy-acetamide
tert-Butyl (1-(4-fluorophenyl)cyclopropyl)carbamate
C14H18FNO2 (251.13215000000002)
Methyl 3-amino-4-(4-methoxyphenyl)-2,2-dimethylbutanoate
(4-((TERT-BUTOXYCARBONYL)(METHYL)AMINO)PHENYL)BORONIC ACID
2-Propen-1-one,3-[4-(dimethylamino)phenyl]-1-phenyl-
6-(Cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine
Rimazolium
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic N - Nervous system > N02 - Analgesics
Lubazodone
C14H18FNO2 (251.13215000000002)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Procainamide 4-hydroxylamine
A benzamide obtained via formal condensation of 4-hydroxylaminobenzoic acid and 2-(diethylamino)ethylamine; a metabolite in liver microsomes.
4-[2-(1-Methyl-1H-benzoimidazol-2-yl)-ethyl]-phenylamine
1-(2,3-dihydro-1H-pyrrol-1-yl)-2-methyldecane-1,3-dione
A member of the class of pyrroles that is 2,3-dihydro-1H-pyrrole substituted by a 2-methyl-3-oxodecanoyl group at the nitrogen atom. Isolated from Penicillium citrinum and Penicillium brevicompactum, it exhibits antifungal activity.
(2E,6E,10R)-10,11-epoxy-3,7,11-trimethyl-2,6-dodecadienoate
(9Z,12Z)-hexadecadienoate
A polyunsaturated fatty acid anion that is the conjugate base of (9Z,12Z)-hexadecadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(4R)-4-[(2R)-6-methyl-4-oxoheptan-2-yl]cyclohexene-1-carboxylate
(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)propan-1-amine
N-(2-methoxyethyl)-2-(5-methyl-4,5,6,7-tetrahydroindazol-2-yl)acetamide
5,7-Dimethyl-2-(1-pyrrolidinyl)-3-quinolinecarbonitrile
Ethyl 2-cyano-3-[(2-oxoazepan-3-yl)amino]prop-2-enoate
(4R)-4,8-dimethylnonyl sulfate
C11H23O4S- (251.13169779999998)
An organosulfate oxoanion that is the conjugate base of (4R)-4,8-dimethylnonyl hydrogen sulfate. It has been isolated from Daphnia pulex and has been found to induce morphological changes in the phytoplankton, Scenedesmus gutwinskii.
N-[2-(2-ethoxyphenoxy)ethyl]-N-methyl-1-butanamine
(9-Methyldecyl)sulfamic acid
A member of the class of sulfamic acids that is sulfamic acid in which one of the amino hydrogens has been replaced by a (9-methyldecyl) group.
Pavettamine
An aminoalcohol that is N(1)-(5-aminopentyl)pentane-1,5-diamine substituted by hydroxy groups at positions 2, 2, 4 and 4 (the 2R,4S,2R,4S-stereoisomer). It is a toxin produced by several plant species and the casual agent of gousiekte (quick disease).
2-(N-Ethyl-m-toluidino)ethanol, TMS derivative
C14H25NOSi (251.17053199999998)
1-Acetyl-4-amino-5-ethyl-2,5-dihydro-1H-pyrrole-3-carbonitrile, TMS derivative
juvenile hormone III carboxylate
A polyunsaturated fatty acid anion obtained by deprotonation of the carboxy group of juvenile hormone III acid; major species at pH 7.3.
Hexadecadienoate
A polyunsaturated fatty acid anion that is the conjugate base of hexadecadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-demethylmirtazapine
A benzazepine metabolite resulting from demethylation of the antidpressant, mirtazapine.